Bergamo Angelo M, Kauweloa Kevin, Gan Gregory, Shi Zheng, Daniels Janeen, Crownover Richard, Narayanasamy Ganesh, Stathakis Sotirios, Mavroidis Panayiotis, Papanikolaou Niko, Gutierrez Alonso
Department of Internal Medicine, Division of Radiation Oncology, University of New Mexico Comprehensive Cancer Center, Albuquerque, NM, USA.
Department of Radiation Oncology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
J Med Phys. 2019 Jul-Sep;44(3):185-190. doi: 10.4103/jmp.JMP_54_18.
The prevention of radiation-induced liver disease (RILD) is very significant in ensuring a safe radiation treatment and high quality of life.
The purpose of this study is to investigate the correlation of physical and biological effective dose (BED) metrics with liver toxicity from hypo-fractionated liver radiotherapy.
41 hypo-fractionated patients in 2 groups were evaluated for classic radiation-induced liver disease (RILD) and chronic RILD, respectively. Patients were graded for effective toxicity (post-treatment minus pre-treatment) using the Common Terminology Criteria for Adverse Events (CTCAE) v4.0. Physical dose (PD) distributions were converted to BED. The V, V, V, V and V physical dose-volume metrics were used in the analysis together with their respective BED-converted metrics of V, V, V, V and V. All levels were normalized to their respective patient normal liver volumes (NLV) and evaluated for correlation to RILD. Results were measured quantitatively using R regression analysis.
The classic RILD group had median follow-up time of 1.9 months and the average PD-NLV normalized V, V, V, V and V metrics per grade were plotted against RILD yielding R correlations of 0.84, 0.72, 0.73, 0.65 and 0.70, respectively while the BED-volume metrics of V, V, V, V and V resulted in correlation values of 0.84, 0.74, 0.66, 0.78 and 0.74, respectively. BED compared to PD showed a statistically significant (p=.03) increase in R for the classic RILD group. Chronic RILD group had median follow-up time of 12.3 months and the average PD-NLV normalized V, V, V, V and V metrics per grade were plotted against RILD grade yielding R correlations of 0.48, 0.92, 0.88, 0.90 and 0.99 while the BED-volume metrics of V, V, V, V and V resulted in correlation values of 0.43, 0.94, 0.99, 0.21 and 0.00, respectively.
The strong correlations of the V and V PD-volume metrics as well as the V (BED of V) to both classic and chronic RILD imply the appropriateness of the current 15 evaluation level for liver toxicity with hypo-fractionated treatments.
预防放射性肝病(RILD)对于确保安全的放射治疗和高质量生活非常重要。
本研究旨在探讨物理和生物等效剂量(BED)指标与低分割肝脏放疗所致肝脏毒性之间的相关性。
对两组41例低分割放疗患者分别评估经典放射性肝病(RILD)和慢性RILD。使用不良事件通用术语标准(CTCAE)v4.0对患者的有效毒性(治疗后减去治疗前)进行分级。将物理剂量(PD)分布转换为BED。分析中使用了V、V、V、V和V物理剂量体积指标及其各自转换为BED的指标V、V、V、V和V。所有水平均根据各自患者的正常肝脏体积(NLV)进行归一化,并评估与RILD的相关性。结果采用R回归分析进行定量测量。
经典RILD组的中位随访时间为1.9个月,将每个分级的平均PD-NLV归一化V、V、V、V和V指标与RILD进行绘图,得出的R相关性分别为0.84、0.72、0.73、0.65和0.70,而V、V、V、V和V的BED体积指标得出的相关值分别为0.84、0.74、0.66、0.78和0.74。与PD相比,经典RILD组的BED在R方面显示出统计学显著增加(p = 0.03)。慢性RILD组的中位随访时间为12.3个月,将每个分级的平均PD-NLV归一化V、V、V、V和V指标与RILD分级进行绘图,得出的R相关性分别为0.48、0.92、0.88、0.90和0.99,而V、V、V、V和V的BED体积指标得出的相关值分别为0.43、0.94、0.99、0.21和0.00。
V和V PD体积指标以及V(V的BED)与经典和慢性RILD的强相关性表明,当前针对低分割治疗肝脏毒性的15评估水平是合适的。